First generation found ABCB1/MDR1/P-gp inhibitors, which included the calcium channel blocker verapamil and the immunosuppressant cyclosporine A, showed effective sensitization of cancer cells which were otherwise resistant to paclitaxel, doxorubicin, and other ABCB1 substrates [24,25]. Here, ABCB1 is linked to cancer.